El rol de la psicoterapia en pacientes oncológicos diagnosticados con trastornos del estado de ánimo que usan psicofármacos.

Abstract

The study analyzes the relationship between psychotherapy and pharmacotherapy in oncology patients with mood disorders. It addresses the issue of how the combination of cognitive-behavioral therapy (CBT) and the use of psychotropic drugs influences the emotional evolution of these patients, considering that cancer affects both their physical health and psychological well-being. The main objective is to describe the use of both therapeutic approaches in a clinical setting and assess their effectiveness. To achieve this, a descriptive meta-analysis was conducted based on a bibliographic review of national and international studies, focusing on oncology patients aged 35 to 75. The results show that depression is highly prevalent in this population. It is evident that combining CBT with pharmacotherapy improves depressive and anxiety symptoms compared to monotherapy. The frequent use of antidepressants and anxiolytics was identified. This study concludes that the combination of psychotherapy and medication is the most effective option for treating mood disorders in oncology patients, highlighting the importance of an interdisciplinary approach to improve these patients’ quality of life.